688029.SH
南微医学
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 73.85
−0.39%Year over year
Reported trailing growth
- Revenue
- +17.8%
- EBITDA
- —
- EBIT
- -1.3%
- EPS
- -2.7%
- Free cash flow
- +42.6%
- Operating cash flow
- +15.3%
Forward estimates
Based on analyst estimates
- Revenue
- -73.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.2%
- EBITDA
- +23.6%
- EBIT
- +23.8%
- Net income
- +19.9%
- EPS
- +19.9%
- Free cash flow
- +127.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026